tffpharma.com - TFFP Company Cash Volume

Official company branding of TFF Pharmaceuticals, Inc. (TFFP)

TFF Pharmaceuticals is winding down its operations, transparently selling off patents due to a capital shortage. Free cash flow levels confirm this decline, where 0.00 records a new baseline. Asset value now relies on the success of partners rather than economic phases. Meanwhile, legal protections in the US completely eliminate the risks of external trade sanctions.

TFFP - TFF Pharma Company Cash Volume over the range 07/04/2022 - 12/21/2024

Metric breakdowns and analytics for TFF Pharmaceuticals, Inc. (TFFP)

- stock value and consensus price forecast:
Comprehensive company analysis:tffpharma.com
Signature product of tffpharma.com

The development of freeze-drying technologies by TFF Pharmaceuticals (TFFP) correlates directly with the dynamics of cash on the balance sheet. This indicator captures actual cash balances, determining the business's real margin of safety against market shocks. The metric measures liquidity through the difference between licensing inflows and operating expenses. While excess capital guarantees survival, it may reduce the overall return on assets, rendering the asset a defensive tool.

Competitors of TFF Pharmaceuticals

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Reserve Lipella Pharmaceuticals Inc|OPTN: Company Cash Volume|Pieris - Company Cash Balance|Company Cash on Hand PROC|Company Cash Volume petrospharma.com|Company Cash Funds Qilian International Corp (QLI)|Company Cash Volume ACELYRIN (SLRN)